Search results for

The erosion of privacy is often pegged to post-Sept. 11 changes in federal law, but some of the most significant moments in our evolution to a less private world have come in the commercial realm.

A New York woman worried that her sore throat might be strep, so she went to the doctor to have it checked out. Then came the bill — with a price tag similar to a small SUV.

Moving the country closer to a shutdown, the Senate rejected a House bill that funded the government but delayed a key part of Obamacare. The ball is now in the House's court.

Forty-one percent of 18- to 29-year-olds give President Trump an F, a Harvard poll shows. Nearly half of this millennial group says politics is relevant, despite low likelihood of running for office.

NPR's Robert Siegel talks with historian Timothy Snyder about his new book, On Tyranny, which explores the new threats faced by our political order and how we can look back to the 20th century for lessons on how to overcome them.

In an era when many kids get a first smartphone at age 10, psychologists say the devices have turned us into Pavlov's dogs — drooling for the next notification, buzz or text. Ready to dial back?

On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter.

Political consultant Stuart Stevens says the Republican Party's support for Trump reflects the abandonment of principles it claimed to embrace, such as fiscal restraint and personal responsibility.

The postings on Facebook, email and WhatsApp are mainly "just words of encouragement and a friendly ear." But they also share food reviews and news.

The Indianapolis-based drugmaker said Monday that it would offer a generic version of Humalog insulin, one of its best-selling medicines. The move could help blunt criticism about high prices.